Total Payments
$701.07
2024 Payments
$289.79
Companies
19
Transactions
48
Medicare Patients
4,898
Medicare Billing
$808,412
Payment Breakdown by Category
Food & Beverage$701.07 (100.0%)
Payments by Nature
| Nature of Payment | Amount | Transactions | Share |
|---|---|---|---|
| Food and Beverage | $701.07 | 48 | 100.0% |
Top Paying Companies
| Company | Total | Records | Latest Year |
|---|---|---|---|
| Novartis Pharmaceuticals Corporation | $135.69 | 20 | $0 (2024) |
| Lundbeck LLC | $97.05 | 4 | $0 (2024) |
| TG Therapeutics, Inc. | $58.59 | 3 | $0 (2024) |
| Eisai Inc. | $49.95 | 1 | $0 (2023) |
| Allergan, Inc. | $41.15 | 2 | $0 (2022) |
| ABBVIE INC. | $39.75 | 2 | $0 (2024) |
| Biogen, Inc. | $32.41 | 2 | $0 (2022) |
| Medtronic, Inc. | $27.52 | 2 | $0 (2024) |
| UCB, Inc. | $26.63 | 1 | $0 (2021) |
| Sunovion Pharmaceuticals Inc. | $23.73 | 2 | $0 (2017) |
Payment History by Year
| Year | Amount | Transactions | Top Company |
|---|---|---|---|
| 2024 | $289.79 | 28 | Novartis Pharmaceuticals Corporation ($135.69) |
| 2023 | $124.65 | 5 | Eisai Inc. ($49.95) |
| 2022 | $111.12 | 6 | Lundbeck LLC ($25.41) |
| 2021 | $151.78 | 7 | UCB, Inc. ($26.63) |
| 2017 | $23.73 | 2 | Sunovion Pharmaceuticals Inc. ($23.73) |
All Payment Transactions
48 individual payment records from CMS Open Payments — Page 1 of 2
| Date | Company | Product | Nature | Form | Amount | Type |
|---|---|---|---|---|---|---|
| 12/20/2024 | Novartis Pharmaceuticals Corporation | KESIMPTA (Drug) | Food and Beverage | In-kind items and services | $22.13 | General |
| Category: Neurology | ||||||
| 12/09/2024 | Novartis Pharmaceuticals Corporation | KESIMPTA (Drug) | Food and Beverage | In-kind items and services | $6.33 | General |
| Category: Neurology | ||||||
| 12/03/2024 | Novartis Pharmaceuticals Corporation | KESIMPTA (Drug) | Food and Beverage | In-kind items and services | $2.74 | General |
| Category: Neurology | ||||||
| 11/08/2024 | Novartis Pharmaceuticals Corporation | KESIMPTA (Drug) | Food and Beverage | In-kind items and services | $5.16 | General |
| Category: Neurology | ||||||
| 10/23/2024 | Medtronic, Inc. | SYNCHROMEDII (Device) | Food and Beverage | In-kind items and services | $15.88 | General |
| Category: Drug Infusion Systems | ||||||
| 10/08/2024 | Genentech USA, Inc. | Ocrevus (Biological), Ocrevus Zunovo | Food and Beverage | In-kind items and services | $19.54 | General |
| Category: Immunology | ||||||
| 10/07/2024 | Novartis Pharmaceuticals Corporation | KESIMPTA (Drug) | Food and Beverage | In-kind items and services | $1.40 | General |
| Category: Neurology | ||||||
| 10/04/2024 | Novartis Pharmaceuticals Corporation | KESIMPTA (Drug) | Food and Beverage | In-kind items and services | $5.31 | General |
| Category: Neurology | ||||||
| 10/04/2024 | Novartis Pharmaceuticals Corporation | KESIMPTA (Drug) | Food and Beverage | In-kind items and services | $1.28 | General |
| Category: Neurology | ||||||
| 09/20/2024 | Lundbeck LLC | VYEPTI (Biological) | Food and Beverage | Cash or cash equivalent | $18.75 | General |
| Category: NEUROLOGY | ||||||
| 09/18/2024 | TG Therapeutics, Inc. | BRIUMVI (Drug) | Food and Beverage | In-kind items and services | $22.00 | General |
| Category: Immunology | ||||||
| 09/09/2024 | Novartis Pharmaceuticals Corporation | KESIMPTA (Drug) | Food and Beverage | In-kind items and services | $17.61 | General |
| Category: Neurology | ||||||
| 08/02/2024 | Novartis Pharmaceuticals Corporation | KESIMPTA (Drug) | Food and Beverage | In-kind items and services | $3.32 | General |
| Category: Neurology | ||||||
| 07/23/2024 | TG Therapeutics, Inc. | BRIUMVI (Drug) | Food and Beverage | In-kind items and services | $16.09 | General |
| Category: Immunology | ||||||
| 07/17/2024 | Novartis Pharmaceuticals Corporation | KESIMPTA (Drug) | Food and Beverage | In-kind items and services | $6.92 | General |
| Category: Neurology | ||||||
| 06/28/2024 | Novartis Pharmaceuticals Corporation | KESIMPTA (Drug) | Food and Beverage | In-kind items and services | $15.80 | General |
| Category: Neurology | ||||||
| 06/17/2024 | Novartis Pharmaceuticals Corporation | KESIMPTA (Drug) | Food and Beverage | In-kind items and services | $4.25 | General |
| Category: Neurology | ||||||
| 06/14/2024 | ABBVIE INC. | UBRELVY (Drug), QULIPTA | Food and Beverage | In-kind items and services | $15.45 | General |
| Category: NEUROSCIENCE | ||||||
| 05/02/2024 | Novartis Pharmaceuticals Corporation | KESIMPTA (Drug) | Food and Beverage | In-kind items and services | $10.26 | General |
| Category: Neurology | ||||||
| 04/02/2024 | Lundbeck LLC | VYEPTI (Biological) | Food and Beverage | Cash or cash equivalent | $32.26 | General |
| Category: NEUROLOGY | ||||||
| 04/01/2024 | Novartis Pharmaceuticals Corporation | KESIMPTA (Drug) | Food and Beverage | In-kind items and services | $4.96 | General |
| Category: Neurology | ||||||
| 04/01/2024 | Novartis Pharmaceuticals Corporation | KESIMPTA (Drug) | Food and Beverage | In-kind items and services | $0.31 | General |
| Category: Neurology | ||||||
| 03/26/2024 | Novartis Pharmaceuticals Corporation | KESIMPTA (Drug) | Food and Beverage | In-kind items and services | $5.80 | General |
| Category: Neurology | ||||||
| 02/23/2024 | Novartis Pharmaceuticals Corporation | KESIMPTA (Drug) | Food and Beverage | In-kind items and services | $12.81 | General |
| Category: Neurology | ||||||
| 02/23/2024 | Novartis Pharmaceuticals Corporation | KESIMPTA (Drug) | Food and Beverage | In-kind items and services | $0.39 | General |
| Category: Neurology | ||||||
Medicare Billing by Year
| Year | Procedures | Beneficiaries | Services | Submitted | Medicare Paid |
|---|---|---|---|---|---|
| 2023 | 12 | 1,132 | 14,681 | $517,080 | $207,240 |
| 2022 | 12 | 1,141 | 13,860 | $460,831 | $188,871 |
| 2021 | 12 | 1,291 | 15,040 | $488,085 | $214,238 |
| 2020 | 14 | 1,334 | 13,193 | $491,337 | $198,062 |
Total Patients
4,898
Total Services
56,774
Medicare Billing
$808,412
Procedure Codes
50
All Medicare Procedures & Services
50 procedure records from CMS Medicare Utilization — Page 1 of 2
| HCPCS | Description | Setting | Year | Patients | Services | Charges | Medicare Paid | Ratio |
|---|---|---|---|---|---|---|---|---|
| J0585 | Injection, onabotulinumtoxina, 1 unit | Office | 2023 | 27 | 13,210 | $125,495 | $60,157 | 47.9% |
| 99214 | Established patient office or other outpatient visit, 30-39 minutes | Office | 2023 | 409 | 585 | $125,190 | $49,917 | 39.9% |
| 99205 | New patient office or other outpatient visit, 60-74 minutes | Office | 2023 | 184 | 184 | $67,528 | $28,540 | 42.3% |
| 99215 | Established patient office or other outpatient visit, 40-54 minutes | Office | 2023 | 116 | 158 | $47,558 | $19,100 | 40.2% |
| 95886 | Needle measurement of electrical activity in arm or leg muscles, complete study | Office | 2023 | 142 | 253 | $58,410 | $17,748 | 30.4% |
| 95911 | Nerve conduction, 9-10 studies | Office | 2023 | 74 | 74 | $34,380 | $10,942 | 31.8% |
| 64615 | Injection of chemical for paralysis of facial and neck nerve muscles on both sides of face | Office | 2023 | 20 | 46 | $12,880 | $5,024 | 39.0% |
| 99213 | Established patient office or other outpatient visit, 20-29 minutes | Office | 2023 | 69 | 80 | $12,080 | $4,766 | 39.5% |
| 95910 | Nerve conduction, 7-8 studies | Office | 2023 | 33 | 33 | $12,295 | $4,179 | 34.0% |
| 95816 | Measurement of brain wave activity (eeg), awake and drowsy | Office | 2023 | 14 | 14 | $9,160 | $2,827 | 30.9% |
| 95909 | Nerve conduction, 5-6 studies | Office | 2023 | 28 | 28 | $7,672 | $2,504 | 32.6% |
| 99204 | New patient office or other outpatient visit, 45-59 minutes | Office | 2023 | 16 | 16 | $4,432 | $1,537 | 34.7% |
| J0585 | Injection, onabotulinumtoxina, 1 unit | Office | 2022 | 29 | 12,500 | $118,750 | $59,127 | 49.8% |
| 99214 | Established patient office or other outpatient visit, 30-39 minutes | Office | 2022 | 348 | 440 | $91,542 | $34,870 | 38.1% |
| 99205 | New patient office or other outpatient visit, 60-74 minutes | Office | 2022 | 165 | 165 | $59,521 | $24,668 | 41.4% |
| 95886 | Needle measurement of electrical activity in arm or leg muscles, complete study | Office | 2022 | 142 | 245 | $52,076 | $18,075 | 34.7% |
| 99215 | Established patient office or other outpatient visit, 40-54 minutes | Office | 2022 | 112 | 128 | $37,793 | $15,913 | 42.1% |
| 95911 | Nerve conduction, 9-10 studies | Office | 2022 | 80 | 82 | $35,753 | $12,189 | 34.1% |
| 99213 | Established patient office or other outpatient visit, 20-29 minutes | Office | 2022 | 159 | 171 | $24,675 | $9,467 | 38.4% |
| 64615 | Injection of chemical for paralysis of facial and neck nerve muscles on both sides of face | Office | 2022 | 21 | 43 | $12,040 | $4,312 | 35.8% |
| 95910 | Nerve conduction, 7-8 studies | Office | 2022 | 29 | 29 | $10,313 | $3,752 | 36.4% |
| 95909 | Nerve conduction, 5-6 studies | Office | 2022 | 31 | 31 | $8,495 | $2,965 | 34.9% |
| 95816 | Measurement of brain wave activity (eeg), awake and drowsy | Office | 2022 | 12 | 13 | $6,342 | $2,579 | 40.7% |
| 99204 | New patient office or other outpatient visit, 45-59 minutes | Office | 2022 | 13 | 13 | $3,531 | $953.52 | 27.0% |
| J0585 | Injection, onabotulinumtoxina, 1 unit | Office | 2021 | 26 | 13,500 | $128,250 | $63,376 | 49.4% |
About Dr. Paul Genilo, MD
Dr. Paul Genilo, MD is a Electrodiagnostic Medicine healthcare provider based in Wichita, Kansas. This provider has been registered with the National Plan and Provider Enumeration System (NPPES) since 06/17/2005. The National Provider Identifier (NPI) number assigned to this provider is 1982609681.
According to the Centers for Medicare & Medicaid Services (CMS) Open Payments database, Dr. Paul Genilo, MD has received a total of $701.07 in payments from pharmaceutical and medical device companies, with $289.79 received in 2024. These payments were reported across 48 transactions from 19 companies. The most common payment nature is "Food and Beverage" ($701.07).
As a Medicare-enrolled provider, Genilo has provided services to 4,898 Medicare beneficiaries, totaling 56,774 services with total Medicare billing of $808,412. Data is available for 4 years (2020–2023), covering 50 distinct procedure/service records.
Ad
Practice Information
- Specialty Electrodiagnostic Medicine
- Other Specialties Neurology
- Location Wichita, KS
- Active Since 06/17/2005
- Last Updated 04/13/2021
- Taxonomy Code 204R00000X
- Entity Type Individual
- NPI Number 1982609681
Products in Payments
- KESIMPTA (Drug) $135.69
- VYEPTI (Biological) $97.05
- BRIUMVI (Drug) $58.59
- Leqembi (Drug) $49.95
- BOTOX (Biological) $41.15
- TYSABRI (Biological) $32.41
- Briviact (Drug) $26.63
- QULIPTA (Drug) $24.30
- APTIOM (Drug) $23.73
- NURTEC ODT (Drug) $21.02
- Omnia (Device) $19.95
- Ocrevus (Biological) $19.54
- BAFIERTAM (Drug) $19.48
- Nourianz (Drug) $18.55
- UPLIZNA (Drug) $18.04
- MAGNETOM Altea (Device) $16.17
- SYNCHROMEDII (Device) $15.88
- UBRELVY (Drug) $15.45
- RELYVRIO (Drug) $14.13
- INTELLIS ADAPTIVESTIM (Device) $11.64
Explore
Data Sources
Provider data from NPPES. Payment data from CMS Open Payments. Medicare data from CMS Medicare Provider Utilization. All data is public and updated periodically.
Electrodiagnostic Medicine Doctors in Wichita
Dr. Gautham Reddy, Md, MD
Electrodiagnostic Medicine — Payments: $1,118
Electrodiagnostic Medicine $1,118
Dr. Bart Grelinger, Md, MD
Electrodiagnostic Medicine — Payments: $566.64
Electrodiagnostic Medicine $566.64
Dr. Ty Schwertfeger, Md, MD
Electrodiagnostic Medicine — Payments: $558.24
Electrodiagnostic Medicine $558.24